| Mature T-Cell and NK-Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 129show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 64 trials (19 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 42 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 41 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 35 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 32 trials (13 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 29 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 27 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 26 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 22 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 17 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |